NIH Director's Pioneer Award (DP1 Clinical Trial Optional)

The NIH Director’s Pioneer Award (DP1) is a high‑risk, high‑reward grant that supports exceptionally creative investigators proposing bold, innovative research that diverges from their current work and from existing efforts in the field. Up to seven awards of $700,000 each will be made, with funding drawn from the NIH Common Fund. Applications are welcome across all NIH‑relevant scientific areas, and a clinical‑trial option is available. The award aims to catalyze transformative discoveries that could reshape major health‑related scientific domains. • Federal grant (Common Fund) – up to 7 awards of $700 K each • Open to a wide range of applicants, including universities, nonprofits, tribal entities, and foreign institutions • Emphasizes high‑risk, high‑reward research that departs from the applicant’s current portfolio • No specific deadline listed; estimated application response date September 9 2027 • Estimated award date August 30 2028; project start September 30 2028 • Contact via e‑mail ([email protected])